Palo Alto, CA – According to filings with the U.S. Securities and Exchange Commission, Theator is raising $15,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tamir Wolf played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Theator

Theator is pioneering the Surgical Intelligence revolution. Our technology is the next generation of AI in surgery û built by surgeons for surgeons, and designed to raise their expertise to the highest possible level. Our goal isn’t just better surgery. It’s to create a whole new experience of AI in surgery. A next-generation OR, with real-time surgical decision support and AI-driven robotic procedures all powered by surgical intelligence. To make this future a reality, we assembled a team of leading surgeons, computer vision experts, clinical specialists, and software developers. Together, we are using real-world scientific data to develop advanced AI capabilities that will fuel more consistently successful surgeries, and ultimately, a healthier world. This is the Surgical intelligence revolution.

To learn more about Theator, visit http://theator.io/

Contact:
Tamir Wolf, Chief Executive Officer
646-935-9217
tamir@theator.io
https://www.linkedin.com/in/tamirwolf/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved